| | | | | | | | | Medical Laboratory Observer has opened submissions for our annual Lab of the Year (LOY) award! Click here to nominate your spectacular lab today! |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | By building strong partnerships, Roche provides high performance instruments, time-saving automation, trusted expertise, and unparalleled service and support. Our dedication to research and development enables HCPs and labs to provide patients with innovative, dependable sexual health testing. Roche’s solutions in molecular testing enable better patient outcomes for everyone, in every community. |
|
|
|
| |
| | |
|
|
| | | | | | The National Institutes of Health has launched a nationwide consortium to address the dramatic rise in youth diagnosed with type 2 diabetes over the past two decades, a trend that is expected to continue. |
|
|
|
| |
| | |
|
|
| | | | | | Infection from COVID-19 appeared to significantly increase the risk of heart attack, stroke, and death for up to three years among unvaccinated people early in the pandemic when the original SARS-CoV-2 virus strain emerged, according to a National Institutes of Health (NIH)-supported study. |
|
|
|
| |
| | |
|
|
| | | | | | QIAGEN announced updates to its sample technologies solutions for non-invasive liquid biopsy applications for use in research and clinical applications such as oncology, prenatal care and organ transplantation. |
|
|
|
| |
| | |
|
|
| | | | | | The FDA approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
